Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | P 33 75 137.4 |
96 | EP file number | EAKZ | 83 81 0548.4 |
97 | EP publication number | EPN | 114027 |
54 | Designation/title | TI | Mevalolacton-Analoga und Derivate, Verfahren zur Herstellung, pharmazeutische Zusammenstellungen die sie enthalten und ihre Verwendung als Arzneimittel. |
51 | IPC main class | ICM (ICMV) | C07D 209/18 (2000.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/405 (2000.01), C07D 405/04 (2000.01) |
22 | DE application date | DAT | Nov 22, 1983 |
96 | EP application date | EAT | Nov 22, 1983 |
43 | Date of first publication | OT | Aug 30, 1984 |
| Date of publication of grant | PET | Jan 7, 1988 |
71/73 | Applicant/owner | INH | Novartis AG, 4056 Basel, CH |
72 | Inventor | IN | Kathawala, Faizulla Gulamhusein, Mountain Lakes, N.J., 07946, US |
74 | Representative | VTR | Spott, Weinmiller & Böhm, 80336 München, DE |
| Address for service | | Patentanwälte Spott, Weinmiller & Böhm, 80336 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 443668 Nov 22, 1982
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 548850 Nov 4, 1983
|
| Patent division in charge | | 44 |
21 | File number of protection certificate | ZAKZ | 194 75 017.5 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, CH, DE, FR, GB, IT, LI, LU, NL, SE |
43 | Date of first publication | EVT | Jul 25, 1984 |
| Date of the first transfer into DPMAregister | EREGT | Sep 25, 2012 |
| Date of the (most recent) update in DPMAregister | REGT | Jan 19, 2013 (Show all update days)(Hide all update days)- Jan 19, 2013
- Historical data not available for this/these date(s)
- Sep 25, 2012
- Date of the first transfer into DPMAregister
|